Neoadjuvant radiochemotherapy (nRCT) can significantly influence the tumor immune architecture that plays a pivotal role in regulating tumor growth. Whereas. various studies have investigated the effect of nRCT on tumor-infiltrating T cells. little is known about its impact on the frequency and activation status of human dendritic cells (DCs). https://stilleners.shop/product-category/differential-gear-set/